{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:39:10Z","timestamp":1794281950482,"version":"4.9.0"},"reference-count":62,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"accepted":{"date-parts":[[2021,11,23]]},"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:p>Posterior reversible encephalopathy syndrome (PRES) may present with diverse clinical symptoms including visual disturbance, headache, seizures and impaired consciousness. MRI shows oedema, usually involving the posterior subcortical regions. Triggering factors include hypertension, pre-eclampsia\/eclampsia, renal failure, cytotoxic agents and autoimmune conditions. The mechanism underlying PRES is not certain, but endothelial dysfunction is implicated. Treatment is supportive and involves correcting the underlying cause and managing associated complications, such as seizures. Although most patients recover, PRES is not always reversible and may be associated with considerable morbidity and even mortality.<\/jats:p>","DOI":"10.1136\/practneurol-2021-003194","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T13:21:15Z","timestamp":1642598475000},"page":"183-189","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":162,"title":["Posterior reversible encephalopathy syndrome (PRES): diagnosis and management"],"prefix":"10.1136","volume":"22","author":[{"given":"James D","family":"Triplett","sequence":"first","affiliation":[{"name":"Neurology, Concord Hospital, Concord, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1001-2024","authenticated-orcid":false,"given":"Mansur Amirovich","family":"Kutlubaev","sequence":"additional","affiliation":[{"name":"Bashkir State Medical University, Ufa, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4476-4016","authenticated-orcid":false,"given":"Allan G","family":"Kermode","sequence":"additional","affiliation":[{"name":"Perron Institute, University of Western Australia, Perth, Western Australia, Australia"},{"name":"CMMIT, Murdoch University, Murdoch, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Hardy","sequence":"additional","affiliation":[{"name":"Neurology, Concord Hospital, Concord, New South Wales, Australia"},{"name":"Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"2025090411475933000_22.3.183.1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2007.46"},{"key":"2025090411475933000_22.3.183.2","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2009.0590"},{"key":"2025090411475933000_22.3.183.3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044534"},{"key":"2025090411475933000_22.3.183.4","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A0549"},{"key":"2025090411475933000_22.3.183.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6152-4"},{"key":"2025090411475933000_22.3.183.6","doi-asserted-by":"crossref","first-page":"468.e1","DOI":"10.1016\/j.ajog.2013.02.015","article-title":"Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia","volume":"208","author":"Brewer","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"2025090411475933000_22.3.183.7","first-page":"393","article-title":"Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin","volume":"8","author":"Reece","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"2025090411475933000_22.3.183.8","first-page":"261","article-title":"Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation","volume":"25","author":"Bartynski","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025090411475933000_22.3.183.9","doi-asserted-by":"publisher","DOI":"10.1177\/0885066610393634"},{"key":"2025090411475933000_22.3.183.10","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3174\/ajnr.A0960","article-title":"Posterior reversible encephalopathy syndrome after solid organ transplantation","volume":"29","author":"Bartynski","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025090411475933000_22.3.183.11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000381316","article-title":"Posterior reversible encephalopathy syndrome in end-stage kidney disease: not strictly posterior or reversible","volume":"41","author":"Canney","year":"2015","journal-title":"Am J Nephrol"},{"key":"2025090411475933000_22.3.183.12","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22047"},{"key":"2025090411475933000_22.3.183.13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/epi.12933","article-title":"Long-term risk of seizures and epilepsy in patients with posterior reversible encephalopathy syndrome","volume":"56","author":"Datar","year":"2015","journal-title":"Epilepsia"},{"key":"2025090411475933000_22.3.183.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6362-9"},{"key":"2025090411475933000_22.3.183.15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm256"},{"key":"2025090411475933000_22.3.183.16","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.572313"},{"key":"2025090411475933000_22.3.183.17","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.68"},{"key":"2025090411475933000_22.3.183.18","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21951"},{"key":"2025090411475933000_22.3.183.19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3174\/ajnr.A0839","article-title":"Catheter angiography, Mr angiography, and MR perfusion in posterior reversible encephalopathy syndrome","volume":"29","author":"Bartynski","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025090411475933000_22.3.183.20","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-017-0460-7"},{"key":"2025090411475933000_22.3.183.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.03.011"},{"key":"2025090411475933000_22.3.183.22","first-page":"1199","article-title":"Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions","volume":"21","author":"Casey","year":"2000","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025090411475933000_22.3.183.23","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A0549"},{"key":"2025090411475933000_22.3.183.24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1743-7563.2012.01544.x","article-title":"Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: a case report and literature review","volume":"8","author":"Femia","year":"2012","journal-title":"Asia Pac J Clin Oncol"},{"key":"2025090411475933000_22.3.183.25","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.5.746"},{"key":"2025090411475933000_22.3.183.26","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm594"},{"key":"2025090411475933000_22.3.183.27","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-008-9096-5"},{"key":"2025090411475933000_22.3.183.28","doi-asserted-by":"crossref","unstructured":"Dasari V , Donohoe CD . Cocaine-Induced posterior reversible encephalopathy syndrome (PRES): a case report and review of the literature. J Neuroimaging Psychiatry Neurol 2018;03.doi:10.17756\/jnpn.2018-025","DOI":"10.17756\/jnpn.2018-025"},{"key":"2025090411475933000_22.3.183.29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/jon.12017","article-title":"Posterior reversible encephalopathy syndrome following a scorpion sting","volume":"23","author":"Porcello Marrone","year":"2013","journal-title":"J Neuroimaging"},{"key":"2025090411475933000_22.3.183.30","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A4563"},{"key":"2025090411475933000_22.3.183.31","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2886"},{"key":"2025090411475933000_22.3.183.32","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00111-8"},{"key":"2025090411475933000_22.3.183.33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jns.2016.12.007","article-title":"Neuroimaging features in posterior reversible encephalopathy syndrome: a pictorial review","volume":"373","author":"Ollivier","year":"2017","journal-title":"J Neurol Sci"},{"key":"2025090411475933000_22.3.183.34","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001026"},{"key":"2025090411475933000_22.3.183.35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2019.07.018","article-title":"Posterior reversible encephalopathy syndrome: a review with emphasis on neuroimaging characteristics","volume":"404","author":"Tetsuka","year":"2019","journal-title":"J Neurol Sci"},{"key":"2025090411475933000_22.3.183.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-009-0632-6"},{"key":"2025090411475933000_22.3.183.37","doi-asserted-by":"publisher","DOI":"10.1177\/1051228404273820"},{"key":"2025090411475933000_22.3.183.38","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.626184"},{"key":"2025090411475933000_22.3.183.39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3174\/ajnr.A0929","article-title":"Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema","volume":"29","author":"Bartynski","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025090411475933000_22.3.183.40","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001940"},{"key":"2025090411475933000_22.3.183.41","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-006-0459-0"},{"key":"2025090411475933000_22.3.183.42","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1212\/01.WNL.0000080369.87484.06","article-title":"Nitroglycerin-aggravated pre-eclamptic posterior reversible encephalopathy syndrome (PRES)","volume":"61","author":"Finsterer","year":"2003","journal-title":"Neurology"},{"key":"2025090411475933000_22.3.183.43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s13760-016-0703-5","article-title":"Predictors of intensive care unit utilization in patients with posterior reversible encephalopathy syndrome","volume":"117","author":"Hinduja","year":"2017","journal-title":"Acta Neurol Belg"},{"key":"2025090411475933000_22.3.183.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2012.02.023"},{"key":"2025090411475933000_22.3.183.45","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e318224688e"},{"key":"2025090411475933000_22.3.183.46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1620\/tjem.226.55","article-title":"Reversible posterior leukoencephalopathy syndrome accompanying eclampsia: correct diagnosis using preoperative MRI","volume":"226","author":"Ekawa","year":"2012","journal-title":"Tohoku J Exp Med"},{"key":"2025090411475933000_22.3.183.47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.seizure.2015.12.005","article-title":"Development of epilepsy after posterior reversible encephalopathy syndrome","volume":"34","author":"Heo","year":"2016","journal-title":"Seizure"},{"key":"2025090411475933000_22.3.183.48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clineuro.2014.06.034","article-title":"Management and outcomes of malignant posterior reversible encephalopathy syndrome","volume":"125","author":"Akins","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"2025090411475933000_22.3.183.49","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1588"},{"key":"2025090411475933000_22.3.183.50","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-009-9200-5"},{"key":"2025090411475933000_22.3.183.51","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1212\/WNL.0000000000006775","article-title":"Pearls & Oy-sters: The dangers of PRES: An atypical case with life-threatening presentation","volume":"92","author":"Catherine","year":"2019","journal-title":"Neurology"},{"key":"2025090411475933000_22.3.183.52","doi-asserted-by":"publisher","DOI":"10.1097\/01.rct.0000233127.21303.b9"},{"key":"2025090411475933000_22.3.183.53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/08037050902975106","article-title":"Recurrent posterior reversible encephalopathy syndrome in mitochondrial disorder","volume":"18","author":"Finsterer","year":"2009","journal-title":"Blood Press"},{"key":"2025090411475933000_22.3.183.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.09.019"},{"key":"2025090411475933000_22.3.183.55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00415-016-8328-4","article-title":"Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin preS study","volume":"264","author":"Siebert","year":"2017","journal-title":"J Neurol"},{"key":"2025090411475933000_22.3.183.56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/ane.12213","article-title":"Discharge status and in-hospital mortality in posterior reversible encephalopathy syndrome","volume":"130","author":"Liman","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"2025090411475933000_22.3.183.57","doi-asserted-by":"crossref","first-page":"421","DOI":"10.21037\/qims.2018.05.07","article-title":"Risk factors for poor outcome in posterior reversible encephalopathy syndrome: systematic review and meta-analysis","volume":"8","author":"Chen","year":"2018","journal-title":"Quant Imaging Med Surg"},{"key":"2025090411475933000_22.3.183.58","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-017-1815-1"},{"key":"2025090411475933000_22.3.183.59","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1277990"},{"key":"2025090411475933000_22.3.183.60","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1113\/JP272450","article-title":"Parasympathetic innervation of vertebrobasilar arteries: is this a potential clinical target?","volume":"594","author":"Roloff","year":"2016","journal-title":"J Physiol"},{"key":"2025090411475933000_22.3.183.61","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3174\/ajnr.A0928","article-title":"Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features","volume":"29","author":"Bartynski","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025090411475933000_22.3.183.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2014.02.022"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/practneurol-2021-003194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T18:48:11Z","timestamp":1757011691000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/practneurol-2021-003194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":62,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,5,17]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/practneurol-2021-003194"],"URL":"https:\/\/doi.org\/10.1136\/practneurol-2021-003194","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]}}}